Exosomes Enhance Diagnosis and Therapy of Ischemic Heart Disease: Insights and Advances.

Researchers reviewed how tiny particles called exosomes might help diagnose and treat heart disease caused by blocked blood vessels. Exosomes are small bubble-like structures that cells release to communicate with each other, carrying important messages through proteins, genetic material, and fats. This review examined scientific evidence showing that exosomes found in blood can reveal early signs of heart damage, helping doctors detect problems before serious symptoms appear. The study also explored how exosomes from stem cells and other beneficial cells might protect the heart and promote healing after injury. While this research focuses on conventional cardiovascular medicine rather than acupuncture specifically, it's worth noting that Traditional Chinese Medicine has long emphasized early disease detection and prevention—concepts that align with the biomarker approach described here. For patients with heart conditions who are considering complementary therapies, acupuncture may offer supportive benefits for stress reduction, blood pressure management, and overall cardiovascular wellness when used alongside standard medical care. Some research suggests acupuncture can improve circulation and reduce inflammation, which are relevant factors in heart health. However, this particular study does not investigate acupuncture's role in heart disease treatment. Anyone with cardiovascular concerns should work closely with their cardiologist before adding complementary approaches. If you're interested in exploring acupuncture as part of a comprehensive heart health strategy, seek a licensed acupuncturist with experience in cardiovascular support.

This review article examines exosome-based approaches for diagnosing and treating ischemic heart disease. Exosomes are extracellular vesicles (30-150 nm) that mediate intercellular communication through transfer of nucleic acids, proteins, and lipids. The authors synthesized current evidence on circulating exosomal biomarkers for early detection, risk stratification, and disease monitoring in myocardial ischemia. Therapeutic applications discussed include exosomes derived from mesenchymal stem cells, immune cells, endothelial cells, and other progenitor cells, which demonstrate cardioprotective effects in preclinical models. No specific sample sizes or effect sizes are provided as this is a narrative review rather than original research. The paper does not address acupuncture or integrative approaches. Clinical relevance for acupuncture practitioners is limited to general awareness of conventional cardiovascular biomarker developments and potential future integration with complementary therapies in multidisciplinary cardiac care settings.